Infugem

Active Ingredient(s): Gemcitabine 0.9% + Sodium Chloride
FDA Approved: * July 16, 2018
Pharm Company: * SUN PHARM INDS INC
Category: Cancer

Gemcitabine, with brand names including Gemzar,[1] is a chemotherapy medication.[2] It treats cancers including testicular cancer,[3] breast cancer, ovarian cancer, non-small cell lung cancer, pancreatic cancer, and bladder cancer.[2][4] It is administered by intravenous infusion.[2] It acts against neoplastic growth, and it inhibits the replication of Orthohepevirus A, the causative agent of Hepat... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Infugem 10 mg/ml Intravenous Injection, Solution
NDC: 62756-008
Labeler:
Sun Pharmaceutical Industries Limited
Infugem 10 mg/ml Intravenous Injection, Solution
NDC: 62756-073
Labeler:
Sun Pharmaceutical Industries Limited
Infugem 10 mg/ml Intravenous Injection, Solution
NDC: 62756-102
Labeler:
Sun Pharmaceutical Industries Limited
Infugem 10 mg/ml Intravenous Injection, Solution
NDC: 62756-219
Labeler:
Sun Pharmaceutical Industries Limited
Infugem 10 mg/ml Intravenous Injection, Solution
NDC: 62756-321
Labeler:
Sun Pharmaceutical Industries Limited
Infugem 10 mg/ml Intravenous Injection, Solution
NDC: 62756-438
Labeler:
Sun Pharmaceutical Industries Limited
Infugem 10 mg/ml Intravenous Injection, Solution
NDC: 62756-533
Labeler:
Sun Pharmaceutical Industries Limited
Infugem 10 mg/ml Intravenous Injection, Solution
NDC: 62756-614
Labeler:
Sun Pharmaceutical Industries Limited
Infugem 10 mg/ml Intravenous Injection, Solution
NDC: 62756-746
Labeler:
Sun Pharmaceutical Industries Limited
Infugem 10 mg/ml Intravenous Injection, Solution
NDC: 62756-974
Labeler:
Sun Pharmaceutical Industries Limited